MX2020000044A - Sales de nicotina y metodos para elaborar y usar las mismas. - Google Patents

Sales de nicotina y metodos para elaborar y usar las mismas.

Info

Publication number
MX2020000044A
MX2020000044A MX2020000044A MX2020000044A MX2020000044A MX 2020000044 A MX2020000044 A MX 2020000044A MX 2020000044 A MX2020000044 A MX 2020000044A MX 2020000044 A MX2020000044 A MX 2020000044A MX 2020000044 A MX2020000044 A MX 2020000044A
Authority
MX
Mexico
Prior art keywords
methods
nicotine salts
making
same
solutions
Prior art date
Application number
MX2020000044A
Other languages
English (en)
Inventor
Jacob Rubenstein
Original Assignee
Nude Nicotine Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nude Nicotine Inc filed Critical Nude Nicotine Inc
Publication of MX2020000044A publication Critical patent/MX2020000044A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B13/00—Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes

Abstract

La presente invención se refiere a composiciones que incluyen sales de nicotina, soluciones de las mismas, métodos de manufactura y métodos de uso. Ciertas modalidades proporcionan el suministro de tales composiciones incluyendo por: modos transdermal, oral, nasal e inhalación. Ciertas modalidades proporcionan sales de nicotina y soluciones de las mismas, adecuadas para, o envasadas en o con dispositivos que incluyen: graqeas orales, goma de mascar, parches transdérmicos, atomizadores intranasales e inhaladores intranasales, liquidos-e, y cigarros-e o dispositivos de vapeo.
MX2020000044A 2017-06-26 2018-06-26 Sales de nicotina y metodos para elaborar y usar las mismas. MX2020000044A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762524892P 2017-06-26 2017-06-26
PCT/US2018/039621 WO2019005889A1 (en) 2017-06-26 2018-06-26 NICOTINE SALTS AND METHODS FOR PREPARING AND USING SAME

Publications (1)

Publication Number Publication Date
MX2020000044A true MX2020000044A (es) 2020-08-06

Family

ID=64741893

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020000044A MX2020000044A (es) 2017-06-26 2018-06-26 Sales de nicotina y metodos para elaborar y usar las mismas.

Country Status (10)

Country Link
US (1) US20200315241A1 (es)
EP (1) EP3644771A4 (es)
JP (1) JP2020525047A (es)
KR (1) KR20200037220A (es)
CN (1) CN111212576A (es)
AU (1) AU2018290848A1 (es)
CA (1) CA3068558A1 (es)
IL (1) IL271736A (es)
MX (1) MX2020000044A (es)
WO (1) WO2019005889A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110167366B (zh) 2016-12-02 2022-04-12 Vmr产品有限责任公司 组合蒸发器
GB201817863D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
EP3714876A1 (de) * 2019-03-29 2020-09-30 VitaSalts AG Verdampfungszusammensetzungen zum inhalieren
EP3714873A1 (de) * 2019-03-29 2020-09-30 VitaSalts AG Basisflüssigkeit für verdampfungszusammensetzungen zum inhalieren
CN110447948A (zh) * 2019-08-20 2019-11-15 深圳多客技术有限公司 电子烟液、其制备方法及制备尼古丁盐、电子烟的新型酸
CN110452219B (zh) * 2019-09-05 2020-06-12 深圳市真味生物科技有限公司 一种尼古丁盐及其制备方法、设备
US20210068447A1 (en) * 2019-09-11 2021-03-11 R. J. Reynolds Tobacco Company Pouched products with enhanced flavor stability
CN111072629A (zh) * 2019-11-22 2020-04-28 云南中烟工业有限责任公司 一种尼古丁-草酸盐复合物晶体及其应用
US11872231B2 (en) 2019-12-09 2024-01-16 Nicoventures Trading Limited Moist oral product comprising an active ingredient
US11826462B2 (en) 2019-12-09 2023-11-28 Nicoventures Trading Limited Oral product with sustained flavor release
US11793230B2 (en) 2019-12-09 2023-10-24 Nicoventures Trading Limited Oral products with improved binding of active ingredients
CA3154417A1 (en) * 2019-12-17 2021-06-24 Philip Morris Products S.A. Aerosol-forming substrate with nitrogen-containing nucleophilic compound
CN111226941B (zh) * 2020-02-15 2021-08-20 浙江大学 一种防治作物害虫的植物源杀虫剂
KR102653443B1 (ko) * 2020-03-25 2024-03-29 선전 필라이프 라이프 사이언스 컴퍼니., 리미티드. 인공 합성 라세미 니코틴 염의 제조 방법
CN114587008B (zh) * 2020-12-07 2023-09-05 深圳雾芯科技有限公司 电子烟液及包含其的雾化装置
CN113197325B (zh) * 2021-05-13 2022-11-04 云南中烟工业有限责任公司 一种基于三维网络结构的超分子凝胶
CA3233375A1 (en) * 2021-09-30 2023-04-06 Michael Zawadzki Oral product with a basic amine and an ion pairing agent
CN113912585B (zh) * 2021-11-09 2023-02-24 深圳萨特瓦生物科技有限公司 复合尼古丁盐及其制备方法与应用、电子烟油及电子烟
WO2023214672A1 (ko) * 2022-05-04 2023-11-09 주식회사 케이티앤지 에어로졸 발생 물품 및 에어로졸 발생 시스템
WO2023214681A1 (ko) * 2022-05-04 2023-11-09 주식회사 케이티앤지 에어로졸 발생 물품 및 에어로졸 발생 시스템
CN114957208A (zh) * 2022-05-22 2022-08-30 南京科技职业学院 一种尼古丁有机盐及其制备方法
CN117281286A (zh) * 2022-06-16 2023-12-26 深圳麦克韦尔科技有限公司 复合烟碱盐、复合烟碱盐调配物及其制备方法和应用
KR20240028723A (ko) * 2022-08-25 2024-03-05 주식회사 케이티앤지 산을 포함하는 흡연물품

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4830028A (en) * 1987-02-10 1989-05-16 R. J. Reynolds Tobacco Company Salts provided from nicotine and organic acid as cigarette additives
DE10013712A1 (de) * 2000-03-20 2001-09-27 Nutrinova Gmbh Nikotinsalze mit verbessertem Geschmack, Verfahren zu ihrer Herstellung und ihre Verwendung
US20030159702A1 (en) * 2002-01-21 2003-08-28 Lindell Katarina E.A. Formulation and use manufacture thereof
SE0201669D0 (sv) * 2002-06-03 2002-06-03 Pharmacia Ab New formulation and use thereof
WO2006004646A1 (en) * 2004-06-28 2006-01-12 Nektar Therapeutics Aerosol formulation comprising nicotine salt
US20080286340A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered nicotine containing products
US20140255452A1 (en) * 2013-03-11 2014-09-11 Niconovum Usa, Inc. Method and apparatus for differentiating oral pouch products
US20140261474A1 (en) * 2013-03-15 2014-09-18 Aradigm Corporation Methods for inhalation of smoke-free nicotine
KR20230013165A (ko) * 2013-05-06 2023-01-26 쥴 랩스, 인크. 에어로졸 장치를 위한 니코틴 염 제제 및 그 방법
AU2014357622B2 (en) * 2013-12-05 2019-10-24 Juul Labs, Inc. Nicotine liquid formulations for aerosol devices and methods thereof
US20150313275A1 (en) * 2014-04-30 2015-11-05 Altria Client Services, Inc. Liquid aerosol formulation of an electronic smoking article
EP3145492A1 (en) * 2014-05-21 2017-03-29 McNeil AB A liquid formulation comprising nicotine for aerosol administration
US10508096B2 (en) * 2014-05-27 2019-12-17 R.J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
US9738622B2 (en) * 2014-05-27 2017-08-22 R.J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
GB2535427A (en) * 2014-11-07 2016-08-24 Nicoventures Holdings Ltd Solution
US20170071248A1 (en) * 2015-09-16 2017-03-16 Sansa Corporation (Barbados) Inc. System and Method for Controlling the Harshness of Nicotine-Based Dry Powder Formulations
US10327472B2 (en) * 2015-09-25 2019-06-25 Altria Client Services Llc Pre-vaporization formulation for controlling acidity in an e-vaping device
EP4338735A2 (en) * 2015-11-25 2024-03-20 R. J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes

Also Published As

Publication number Publication date
CA3068558A1 (en) 2019-01-03
US20200315241A1 (en) 2020-10-08
JP2020525047A (ja) 2020-08-27
AU2018290848A1 (en) 2020-02-13
WO2019005889A1 (en) 2019-01-03
IL271736A (en) 2020-02-27
CN111212576A (zh) 2020-05-29
EP3644771A4 (en) 2021-11-17
EP3644771A1 (en) 2020-05-06
KR20200037220A (ko) 2020-04-08

Similar Documents

Publication Publication Date Title
MX2020000044A (es) Sales de nicotina y metodos para elaborar y usar las mismas.
MX2020012810A (es) Formulación de nicotina.
MY177136A (en) Tobacco-based nicotine aerosol generation system
PH12016501719A1 (en) Flavoured nicotine powder inhaler
MX2018006997A (es) Composicion de tabaco.
MX2021002579A (es) Formulaciones de sal de nicotina para dispositivos de aerosol y metodos de los mismos.
WO2011013003A3 (en) Intranasal granisetron and nasal applicator
EA201291306A1 (ru) Состав сухого порошка, содержащий антимускариновое средство
MX2016015179A (es) Una formulación líquida que comprende nicotina para administracion en aerosol.
SE1750679A1 (en) Nicotine-containing chewing gum compositions
EP3113821A4 (fr) Masque facial pour inhalation, adapte a l'administration d'un gaz ou d'une molécule thérapeutique dans le cadre d'un traitement par inhalation, en particulier chez les enfants
MX2016014089A (es) Inhalador de polvo de nicotina.
CL2017003066A1 (es) Composiciones de carbonato de calcio amorfo para administración mediante inhalación, sublingual o bucal
EA201491281A1 (ru) КОМПОЗИЦИЯ В ФОРМЕ СУХОГО ПОРОШКА, СОДЕРЖАЩАЯ КОРТИКОСТЕРОИД И β-АДРЕНЕРГИЧЕСКОЕ ЛЕКАРСТВЕННОЕ СРЕДСТВО, ДЛЯ ВВЕДЕНИЯ ИНГАЛЯЦИЕЙ
AU2017379247A8 (en) Pharmaceutical dosage forms containing TASK-1 and TASK-3 channel inhibitors, and the use of same in breathing disorder therapy
TR200907917A2 (tr) Kuru toz inhaleri.
EA201591415A1 (ru) Фармацевтические композиции, включающие многокомпонентные кристаллические частицы, подходящие для применения в ингаляционной терапии
MX2015015150A (es) Composiciones farmaceuticas inhalables y los dispositivos inhaladores que las contienen.
EA202193343A1 (ru) Вдыхаемая композиция, содержащая циклодекстрин, для применения при лечении назальных воспалений
IL250852B (en) Periodontal preparation
WO2023130041A3 (en) Nicotine delivery systems
EA202091618A1 (ru) Композиция кетамина в виде сухого порошка для применения при лечении депрессии ингаляционным путем
MX365285B (es) Complejo lubricante para la boca.
MX2014001940A (es) Producto farmaceutico de aerosol para administracion por inhalacion oral o nasal.
PH12015501179A1 (en) Fixed dose pharmaceutical composition comprising mometasone and azelastine